What is XPER's health score?

Xperi Inc. (XPER) has a TradeApes health score of 38 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is XPER's estimated fair value?

Based on our 5-year discounted cash flow model, Xperi Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is XPER undervalued or overvalued?

Our model currently rates XPER as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for XPER... Refresh in a moment for the full analysis.

Xperi Inc. (XPER)

Technology Inconclusive inconclusive weak

$7.48

Updated: 2026-06-05

TradeApes Score

Financial Strength

35 Weak

Operating Trend

40 Weak

Relative Value

20 Stressed

Capital Allocation

50 Mixed

Risk

70 Healthy

Key Findings

+ Strong FCF growth — free cash flow up more than 20% year over year

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.